BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23040008)

  • 1. Emergence of OXA-48-producing Enterobacteriaceae in Switzerland.
    Potron A; Schrenzel J; Poirel L; Renzi G; Cherkaoui A; Nordmann P
    Int J Antimicrob Agents; 2012 Dec; 40(6):563-4. PubMed ID: 23040008
    [No Abstract]   [Full Text] [Related]  

  • 2. OXA-48-like carbapenemase-producing Enterobacteriaceae in Ottawa, Canada.
    Ellis C; Chung C; Tijet N; Patel SN; Desjardins M; Melano RG; Toye B
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):399-400. PubMed ID: 23711532
    [No Abstract]   [Full Text] [Related]  

  • 3. Emergence of OXA-48 carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in dogs.
    Stolle I; Prenger-Berninghoff E; Stamm I; Scheufen S; Hassdenteufel E; Guenther S; Bethe A; Pfeifer Y; Ewers C
    J Antimicrob Chemother; 2013 Dec; 68(12):2802-8. PubMed ID: 23833179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of the IMP-8 metallo-β-lactamase in the Escherichia coli ST131 clone in Taiwan.
    Yan JJ; Tsai LH; Wu JJ
    Int J Antimicrob Agents; 2012 Sep; 40(3):281-2. PubMed ID: 22789726
    [No Abstract]   [Full Text] [Related]  

  • 5. Emergence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae during the years 2000 and 2004 in Helsinki, Finland.
    Forssten SD; Kolho E; Lauhio A; Lehtola L; Mero S; Oksaharju A; Jalava J; Tarkka E; Vaara M; Vuopio-Varkila J
    Clin Microbiol Infect; 2010 Aug; 16(8):1158-61. PubMed ID: 20670290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESBL-producing E. coli and K. pneumoniae in Al-Ahsa, Saudi Arabia: antibiotic susceptibility and prevalence of blaSHV and blaTEM.
    Alsultan AA; Aboulmagd E; Amin TT
    J Infect Dev Ctries; 2013 Dec; 7(12):1016-9. PubMed ID: 24334953
    [No Abstract]   [Full Text] [Related]  

  • 7. Multicentre investigation of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in German hospitals.
    Kaase M; Schimanski S; Schiller R; Beyreiß B; Thürmer A; Steinmann J; Kempf VA; Hess C; Sobottka I; Fenner I; Ziesing S; Burckhardt I; von Müller L; Hamprecht A; Tammer I; Wantia N; Becker K; Holzmann T; Furitsch M; Volmer G; Gatermann SG
    Int J Med Microbiol; 2016 Sep; 306(6):415-20. PubMed ID: 27237423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nosocomial outbreak of Klebsiella pneumoniae harbouring bla(KPC-3) in France subsequent to a patient transfer from Italy.
    Cuzon G; Naas T; Demachy MC; Nordmann P
    Int J Antimicrob Agents; 2012 May; 39(5):448-9. PubMed ID: 22421327
    [No Abstract]   [Full Text] [Related]  

  • 9. Emergence of bla(OXA-181)-carrying ColE plasmid in Klebsiella pneumoniae in Australia.
    Sidjabat HE; Kennedy K; Silvey A; Collignon P; Paterson DL
    Int J Antimicrob Agents; 2013 Mar; 41(3):294-6. PubMed ID: 23313398
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3.
    Lee SY; Park YJ; Yu JK; Jung S; Kim Y; Jeong SH; Arakawa Y
    J Antimicrob Chemother; 2012 Dec; 67(12):2843-7. PubMed ID: 22893681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and phenotypic characterization of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases with focus on CTX-M in a low-endemic area in Sweden.
    Onnberg A; Mölling P; Zimmermann J; Söderquist B
    APMIS; 2011 Apr; 119(4-5):287-95. PubMed ID: 21492229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominance of CTX-M-2 and CTX-M-56 among extended-spectrum beta-lactamases produced by Klebsiella pneumoniae and Escherichia coli isolated in hospitals in Paraguay.
    Khan MA; Lemmens N; Riera E; Blonk T; Goedhart J; Van Belkum A; Goessens W; Hays JP; Van Westreenen M
    J Antimicrob Chemother; 2009 Dec; 64(6):1330-2. PubMed ID: 19854861
    [No Abstract]   [Full Text] [Related]  

  • 13. Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals.
    Ensor VM; Shahid M; Evans JT; Hawkey PM
    J Antimicrob Chemother; 2006 Dec; 58(6):1260-3. PubMed ID: 17071956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful control of a hospital-wide outbreak of OXA-48 producing Enterobacteriaceae in the Netherlands, 2009 to 2011.
    Dautzenberg MJ; Ossewaarde JM; de Kraker ME; van der Zee A; van Burgh S; de Greeff SC; Bijlmer HA; Grundmann H; Cohen Stuart JW; Fluit AC; Troelstra A; Bonten MJ
    Euro Surveill; 2014 Mar; 19(9):. PubMed ID: 24626209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of NDM-1-producing Enterobacteriaceae in Norway.
    Samuelsen Ø; Thilesen CM; Heggelund L; Vada AN; Kümmel A; Sundsfjord A
    J Antimicrob Chemother; 2011 Mar; 66(3):670-2. PubMed ID: 21172785
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia.
    Severin JA; Mertaniasih NM; Kuntaman K; Lestari ES; Purwanta M; Lemmens-Den Toom N; Duerink DO; Hadi U; van Belkum A; Verbrugh HA; Goessens WH;
    J Antimicrob Chemother; 2010 Mar; 65(3):465-9. PubMed ID: 20053690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae in Danish hospitals; this is in part explained by spread of two CTX-M-15 clones with multilocus sequence types 15 and 16 in Zealand.
    Lester CH; Olsen SS; Jakobsen L; Arpi M; Fuursted K; Hansen DS; Heltberg O; Holm A; Højbjerg T; Jensen KT; Johansen HK; Justesen US; Kemp M; Knudsen JD; Røder B; Frimodt-Møller N; Hammerum AM
    Int J Antimicrob Agents; 2011 Aug; 38(2):180-2. PubMed ID: 21612893
    [No Abstract]   [Full Text] [Related]  

  • 18. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence study on carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolates in Czech hospitals--results from Czech Part of European Survey on Carbapenemase--Producing Enterobacteriaceae (EuSCAPE).
    Hrabák J; Študentová V; Jakubů V; Adámková V; Dvořáková L; Balejova M; Bergerová T; Chmelařová E; Ježek P; Kabelíková P; Kolář M; Paterová P; Tejkalová R; Papagiannitsis C; Žemličková H
    Epidemiol Mikrobiol Imunol; 2015 Jun; 64(2):87-91. PubMed ID: 26099612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Klebsiella pneumoniae co-producing NDM-7 and OXA-181, Escherichia coli producing NDM-5 and Acinetobacter baumannii producing OXA-23 in a single patient.
    Hammerum AM; Littauer P; Hansen F
    Int J Antimicrob Agents; 2015 Nov; 46(5):597-8. PubMed ID: 26307465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.